Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 1
2008 1
2009 2
2010 4
2011 4
2012 1
2013 1
2014 1
2015 1
2016 3
2018 1
2019 2
2020 10
2021 6
2022 6
2023 6
2024 10
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Chez les sujets avec insuffisance cardiaque à fraction d’éjection diminuée avec ou sans diabète de type 2, est-ce que la dapagliflozine, un inhibiteur des SGLT2, est efficace pour prévenir l’insuffisance cardiaque décompensée ou la mortalité cardiovasculaire tout en étant sécuritaire ?
Lanthier L, Dussault C, Huard G, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2020 Feb;41(2):143-144. doi: 10.1016/j.revmed.2019.12.011. Epub 2020 Jan 9. Rev Med Interne. 2020. PMID: 31928796 French. No abstract available.
[Among patients with acute myocardial infarction who had undergone coronary angiography and with preserved left ventricular ejection fraction, does long-term beta-blocker therapy lower the risk of death or recurrent myocardial infarction?].
Lanthier L, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2024 Jul;45(7):453-454. doi: 10.1016/j.revmed.2024.05.024. Epub 2024 Jun 6. Rev Med Interne. 2024. PMID: 38845251 French. No abstract available.
[In pregnant women with mild chronic hypertension, does a treatment strategy using a treatment target<140/90mmHg compared to watchful waiting unless BP>160/105mmHg reduce the incidence of maternal and perinatal complications while being safe?].
Lanthier L, Sauvé N, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2022 Aug;43(8):514-515. doi: 10.1016/j.revmed.2022.07.003. Epub 2022 Jul 19. Rev Med Interne. 2022. PMID: 35868989 French. No abstract available.
[In patients with type 2 diabetes on metformin, the addition of which antihyperglycemic class among a sulfonylurea (glimepiride), a DPP-4 inhibitor (sitagliptin), a GLP-1 agonist (liraglutide), or basal insulin (glargine) is the most effective to achieve and maintain good glycemic control?].
Lanthier L, Mutchmore A, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2023 Jan;44(1):48-49. doi: 10.1016/j.revmed.2022.11.005. Epub 2022 Nov 25. Rev Med Interne. 2023. PMID: 36443201 French. No abstract available.
57 results